Information Provided By: 
Fly News Breaks for November 14, 2019
MYO
Nov 14, 2019 | 05:58 EDT
Roth Capital analyst Scott Henry downgraded Myomo to Neutral from Buy with a price target of 55c, down from $1.75. The analyst sees lowered future expectations for the company after its Q3 results missed expectations. Myomo's focus appears more on backlog than the pipeline, and its current backlog does not indicate an inflection point in the coming two quarters, Henry tells investors in a research note. Further, he believes a capital infusion "appears a near-term event."
News For MYO From the Last 2 Days
There are no results for your query MYO
